Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-16

Clinical Trial Update: Hexadecanal as an Addon to Cognitive Processing Therapy for PTSD [NA]

View source ↗

Summary

A clinical trial evaluating hexadecanal as an add-on to Cognitive Processing Therapy for PTSD is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hexadecanal (hexadecanal)

Snippet

Sponsor: Tel Aviv University | Conditions: Post Traumatic Stress Disorder (PTSD) | NA | Status: RECRUITING